VILDAGLIPTIN NOBEL cpr 50 mg 28 pce
7680687500012
CH-68750
A10BH02
07.06.2.
Reimbursement limitations:
GALVUS4
Pour le traitement des patients diabétiques de type 2, lorsque un régime alimentaire et une …
1 / 3
google
Details
- Product number
- 6875001
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- vildagliptinum 50 mg, lactosum 10 mg, cellulosum microcristallinum, carboxymethylamylum natricum A corresp. natrium 0.112 - 0.168 mg, magnesii stearas, pro compresso obducto.
Articles (1)
Vildagliptin NOBEL 50 mg, Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
10.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 27.80
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
NOBEL Pharma Schweiz AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 68750
- Drug name
- Vildagliptin NOBEL, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BH02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 26/09/2022
- Authorization expiration date
- 25/09/2027
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VILDAGLIPTIN NOBEL cpr 50 mg 28 pce
- Description (DE)
- VILDAGLIPTIN NOBEL Tabl 50 mg 28 Stk
- Market launch
- 29/04/2023
- Narcotic (BTM)
- No